Orthopedics. 2021 Jan 1;44(1):e80-e84. doi: 10.3928/01477447-20200928-01. Epub 2020 Oct 1.
New Jersey State Law, P.L. 2017 Chapter 28 22, C.24:21-15.2, passed in February 2017, is the most restrictive opioid legislation passed thus far in the United States. This study evaluated the effects of this legislation on the postoperative opioid prescriptions of patients undergoing arthroscopic rotator cuff repair (RCR). Opioid prescriptions were compared following arthroscopic RCR before and after implementation of the new law using the New Jersey Prescription Monitoring Program Aware Drug Database. A consecutive cohort of patients who underwent RCR during a 6-month period prior to the legislation was compared with a consecutive cohort of patients who underwent RCR during a 6-month period after the law went into effect. The primary outcome measure was prescribed postoperative milligram morphine equivalents (MME) and number of pills prescribed. There were 265 patients in the pre-law cohort and 198 patients in the post-law cohort. In the pre-law cohort, there was a median of 1250 MME (interquartile range [IQR], 900-1800 MME) and a median of 100 pills (IQR, 60-175 pills) prescribed postoperatively. In the post-law cohort, a median of 900 MME (IQR, 550-1050 MME) and a median of 60 pills (IQR, 60-90 pills) were prescribed postoperatively. A comparison of pre-law and post-law data for MME and number of pills prescribed was statistically significant (P<.001). The median opioid consumption MME and number of pills prescribed following RCR decreased significantly following the implementation of the New Jersey state law. Findings of this study indicate state regulations may play a role in reducing narcotic consumption following RCR. [Orthopedics. 2021;44(1):e80-e84.].
新泽西州法律，P.L. 2017 第 28 章 22，C.24:21-15.2，于 2017 年 2 月通过，是迄今为止美国通过的最严格的阿片类药物立法。本研究评估了该立法对接受关节镜肩袖修复（RCR）的患者术后阿片类药物处方的影响。使用新泽西州处方监测计划意识药物数据库，在该新法律实施前后，通过关节镜 RCR 比较了阿片类药物处方。将在立法前 6 个月内接受 RCR 的连续队列患者与在法律生效后 6 个月内接受 RCR 的连续队列患者进行比较。主要观察指标是规定的术后毫克吗啡当量（MME）和规定的药丸数。在法律前队列中有 265 例患者，在法律后队列中有 198 例患者。在法律前队列中，中位数为 1250 MME（四分位距[IQR]，900-1800 MME），术后中位数为 100 片（IQR，60-175 片）。在法律后队列中，中位数为 900 MME（IQR，550-1050 MME），术后中位数为 60 片（IQR，60-90 片）。MME 和规定药丸数的术前和术后数据比较具有统计学意义（P<.001）。在新泽西州法律实施后，接受 RCR 后阿片类药物消耗的中位数 MME 和规定药丸数显著减少。本研究的结果表明，州法规可能在减少 RCR 后阿片类药物的消耗方面发挥作用。[骨科。2021;44(1):e80-e84.]。
